Pain mitigation company Calmare Therapeutics is facing an investor suit filed this week in New York federal court claiming the company made false statements and misled investors. Investors in the suit are looking to recover millions of dollars of damages caused by the company’s’ alleged illegal conduct, citing violations of federal security laws and the dissemination […]
Calmare Therapeutics Inc
Bayer taps strategy head Baumann for CEO | Personnel Moves
Bayer (ETR:BAYN) named strategy chief Werner Baumann to replace Marijn Dekkers as CEO today, prompting some industry watchers to speculate that there’s more deal-making ahead for the German firm’s non-pharma markets. Baumann, who’s slated to succeed Dekkers May 1, joined Bayer in 1988 and made a name for himself with the successful integration of rival drugmaker […]
Calmare wins $15m DoD contract
Pain mitigation company Calmare Therapeutics said yesterday it won a general supply order contract from the U.S. Department of Defense for an estimated $15 million over the next 60 months. The Fairfield, Conn.-based company’s flagship product is its Calmare Pain Therapy Device, which is designed as a non-invasive and non-addictive neuropathic pain treatment modality, and has […]
